Remdesivir Intermediate CAS 1354823-36-1 COVID-19
Manufacturer Commercial Supply Remdesivir and Related Intermediates with High Quality
Remdesivir CAS 1809249-37-3
2-Ethyl-1-butanol CAS 97-95-0
Trimethylsilyl Cyanide CAS 7677-24-9
4-Nitrophenol CAS 100-02-7
2-Ethylbutyl ((S)-(perfluorophenoxy)(phenoxy)phosphoryl)-L-alaninate CAS 1911578-98-7
N-[(S)-(4-nitrophenoxy)phenoxyphosphinyl]-L-Alanine 2-ethylbutyl ester CAS 1354823-36-1
(S)-2-Ethylbutyl 2-Aminopropanoate Hydrochloride CAS 946511-97-3
Remdesivir Metabolite (GS-441524) CAS 1191237-69-0
Remdesivir N-2 Intermediate CAS 1191237-80-5
2,3,5-Tri-O-benzyl-D-ribonolactone CAS 55094-52-5
7-Bromopyrrolo[2,1-f][1,2,4]triazin-4-amine CAS 937046-98-5
Pyrrolo[1,2-F][1,2,4]Triazin-4-Amine CAS 159326-68-8
4-Amino-7-iodopyrrolo[2,1-f][1,2,4]triazine CAS 1770840-43-1
Chemical Name | N-[(S)-(4-nitrophenoxy)phenoxyphosphinyl]-L-Alanine 2-ethylbutyl ester |
Synonyms | Remdesivir Intermediate; Remdesivir Side Chain; Remdesivir p-NitroPhenoxy L-Alanine Impurity; Remdesivir Impurity 4; Remdesivir-002; (S)-2-Ethylbutyl 2-(((S)-(4-nitrophenoxy)(phenoxy)-phosphoryl)-amino)propanoate; Remdesivir-002-SS |
CAS Number | 1354823-36-1 |
Stock Status | In Stock, Production Scale Up to Hundreds of Kilograms |
Molecular Formula | C21H27N2O7P |
Molecular Weight | 450.42 |
Density | 1.241±0.06 g/cm3 |
COA & MSDS | Available |
Place of Origin | China |
Product Categories | Remdesivir Intermediate |
Brand | Ruifu Chemical |
Item | Specifications |
Appearance | White to Almost White Powder |
Identification | IR, HPLC |
Loss on Drying | ≤1.00% |
Single Impurity | ≤0.50% |
Heavy Metals | ≤20ppm |
Purity | ≥98.0% |
Test Standard | Enterprise Standard |
Usage | Intermediate of Remdesivir (CAS 1809249-37-3); COVID-19 |
Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer's requirement.
Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture.
N-[(S)-(4-nitrophenoxy)phenoxyphosphinyl]-L-Alanine 2-ethylbutyl ester (CAS 1354823-36-1, also known as Remdesivir Impurity 4) is a phosphoramidate sidechain typically used for the preparation of Remdesivir (CAS 1809249-37-3, GS-5734), which is a novel antiviral investigational drug originally for the treatment of Ebola virus disease and Marburg virus infections and has subsequently also been found to show antiviral activity against coronaviruses (e.g. SARS-Cov-2/Covid-19). During the outbreak of the new Coronavirus Disease 2019 (COVID-19), Remdesivir (CAS 1809249-37-3) is one of the COVID-19 related research products. Remdesivir, sold under the brand name Veklury, is a broad-spectrum antiviral medication developed by the biopharmaceutical company Gilead Sciences. It is administered via injection into a vein. During the COVID-19 pandemic, Remdesivir was approved or authorized for emergency use to treat COVID-19 in around 50 countries. Updated guidelines from the World Health Organization in November 2020 include a conditional recommendation against the use of Remdesivir for the treatment of COVID-19.